In order to progress to a personalised medicine trial of CLA in IBD, a partner diagnostic test that can demonstrate altered NF-κB dynamics in patients' peripheral blood monocyte-derived macrophages is under development (Papoutsopoulou et al., 2019). The gene discussed is NFKB1; the disease is inflammatory bowel disease.